Exelixis
EXEL
#1562
Rank
S$17.98 B
Marketcap
S$72.57
Share price
0.11%
Change (1 day)
45.86%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company